» Articles » PMID: 30158679

Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing

Overview
Journal Sci Rep
Specialty Science
Date 2018 Aug 31
PMID 30158679
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Maternal antibodies contribute to the protection of young infants from infectious diseases during the early life. However, vaccinations for women of child-bearing age are not routine in China. Therefore, we investigated the level of protective immunity against vaccine preventable diseases in pregnant women and newborns in China. A total of 194 paired maternal and cord blood samples were collected in Beijing from 2016 to 2017. Antibodies specific for the antigens covered by diphtheria-tetanus-pertussis (DTP) and measles-mumps-rubella (MMR) vaccine were determined by ELISA (Euroimmun, Lübeck, Germany). The cut off value of ≥0.1 IU/ml (anti-diphtheria), >0.1 IU/ml (anti-tetanus), >40 IU/ml (anti-pertussis toxin), ≥200 IU/l (anti-measles), ≥45 RU/ml (anti-mumps) and ≥10 IU/ml (anti-rubella) were used to assess the percentage of newborns with protective IgG concentrations, respectively. The results revealed that 61.3%, 73.2%, 97.4%, 30.4%, 65.5% and 17.0% of newborns had no protection against diphtheria, tetanus, pertussis, measles, mumps and rubella. Only 1.0% and 23.7% of newborns had protection against all three components of DTP or MMR, respectively. The finding suggested that most of newborns were susceptible to diphtheria, tetanus, pertussis and mumps, almost one-third of this population had no immune protection against measles, and about one-sixth of them were under threat of rubella infection. These data supported the immunization program for DTP and MMR vaccine in women at child-bearing age.

Citing Articles

Persistence of Antibodies against Measles, Mumps, and Rubella after the Two-Dose MMR Vaccination: A 7-Year Follow-Up Study.

Sarawanangkoor N, Wanlapakorn N, Srimuan D, Thatsanathorn T, Thongmee T, Poovorawan Y Vaccines (Basel). 2024; 12(7).

PMID: 39066382 PMC: 11281446. DOI: 10.3390/vaccines12070744.


Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysis.

Zhu Y, Zhang W, Hu J, Luo S, Zhou Y, Tang X Hum Vaccin Immunother. 2024; 20(1):2341454.

PMID: 38695296 PMC: 11067989. DOI: 10.1080/21645515.2024.2341454.


COVID-19 booster enhances IgG mediated viral neutralization by human milk .

Valcarce V, Stafford L, Neu J, Parker L, Vicuna V, Cross T Front Nutr. 2024; 11:1289413.

PMID: 38406184 PMC: 10884187. DOI: 10.3389/fnut.2024.1289413.


Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT.

Lutz C, Hasan A, Bolotin S, Crowcroft N, Cutts F, Joh E BMC Infect Dis. 2023; 23(1):367.

PMID: 37259032 PMC: 10231861. DOI: 10.1186/s12879-023-08199-8.


Seroepidemiology of pertussis and diphtheria among healthy adults in Shaanxi Province, northwest China: A large - scale cross-sectional study.

Zhang C, Hu W, Wang R, Wang Y, Li Y, Lv Y Hum Vaccin Immunother. 2022; 18(6):2133913.

PMID: 36255248 PMC: 9746365. DOI: 10.1080/21645515.2022.2133913.


References
1.
Vilajeliu A, Gonce A, Lopez M, Costa J, Rocamora L, Rios J . Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn. Vaccine. 2015; 33(8):1056-62. DOI: 10.1016/j.vaccine.2014.12.062. View

2.
Wang Z, Yan R, He H, Li Q, Chen G, Yang S . Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination. PLoS One. 2014; 9(2):e89361. PMC: 3930734. DOI: 10.1371/journal.pone.0089361. View

3.
Xiong Y, Wang D, Lin W, Tang H, Chen S, Ni J . Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China. Hum Vaccin Immunother. 2014; 10(4):1097-03. PMC: 4896514. DOI: 10.4161/hv.27734. View

4.
Plans P, de Ory F, Campins M, Alvarez E, Paya T, Guisasola E . Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013. Eur J Clin Microbiol Infect Dis. 2015; 34(6):1161-71. DOI: 10.1007/s10096-015-2339-4. View

5.
Tahita M, Hubschen J, Tarnagda Z, Ernest D, Charpentier E, Kremer J . Rubella seroprevalence among pregnant women in Burkina Faso. BMC Infect Dis. 2013; 13:164. PMC: 3623657. DOI: 10.1186/1471-2334-13-164. View